Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma.
Cichocki F, Bjordahl R, Goodridge JP, Mahmood S, Gaidarova S, Abujarour R, Davis ZB, Merino A, Tuininga K, Wang H, Kumar A, Groff B, Witty A, Bonello G, Huffman J, Dailey T, Lee TT, Malmberg KJ, Walcheck B, Höpken U, Rehm A, Valamehr B, Miller JS.
Cichocki F, et al. Among authors: rehm a.
Nat Commun. 2022 Nov 29;13(1):7341. doi: 10.1038/s41467-022-35127-2.
Nat Commun. 2022.
PMID: 36446823
Free PMC article.